← Back to Search

Educational Program for Epilepsy (C2CEDRCT Trial)

N/A
Waitlist Available
Led By Kathy N Speechley, PhD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults (aged ≥18 years) visiting a participating ED for a seizure or an epilepsy-related concern.
Adults on anti-seizure medication prior to coming to the ED or prescribed anti-seizure medication at the ED.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout study completion, approximately 2 years
Awards & highlights

C2CEDRCT Trial Summary

This trial is testing whether a program called Clinic to Community can help adults with epilepsy who visit emergency departments. The program provides patient education to improve knowledge of epilepsy and access to community-based services. The goal is to see if the program can reduce the frequency of ED visits, reduce felt stigma and improve quality of life, epilepsy knowledge, and self-management skills.

Who is the study for?
This trial is for English-speaking adults over 18 who visit the emergency department (ED) for seizures or epilepsy-related issues and are on anti-seizure medication. It's not open to those who've already done the Clinic To Community© program or have a diagnosis of psychogenic non-epileptic seizures.Check my eligibility
What is being tested?
The study tests the Clinic To Community© education program, aiming to teach patients about epilepsy and connect them with community services. Participants are randomly chosen to either start the program immediately or wait 12 months, assessing its impact on ED visits and quality of life.See study design
What are the potential side effects?
Since this intervention involves an educational program rather than a medical treatment, there aren't typical side effects like you'd see with drugs. However, participants may experience varying levels of stress or anxiety related to their involvement.

C2CEDRCT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Adults who are 18 years or older and come to a certain hospital for a seizure or epilepsy-related problem.
Select...
Adults who are taking seizure medication before coming to the emergency room or are prescribed seizure medication at the emergency room.

C2CEDRCT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout study completion, approximately 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout study completion, approximately 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of engagement with the Clinic To Community© (C2C) program
Secondary outcome measures
Effect of participation in C2C on epilepsy knowledge
Effect of participation in C2C on felt stigma using "Epilepsy Stigma Scale"
Effect of participation in C2C on felt stigma using "Stigma Scale of Epilepsy"
+3 more
Other outcome measures
Effect on Psychiatric comorbidities using Brief Symptom Inventory
Effect on activities of daily living using Sheehan Disability Scale
Effect on anxiety using Generalized Anxiety Disorder 7-item (GAD-7) scale
+4 more

C2CEDRCT Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist Control GroupExperimental Treatment1 Intervention
Waitlist Control Group. The control group continues TAU and will be followed up 12 months after randomization. The control group will receive C2C after the 12-month follow-up.
Group II: Intervention GroupExperimental Treatment1 Intervention
Intervention Group. Participants randomized to the intervention group will complete the C2C program. They will receive an in-person one-on-one 60-minute education session and will be introduced to, and encouraged to participate in, the programs and support services that are provided by Epilepsy Southwestern Ontario (ESWO). As part of the C2C program, participants will be contacted 6 months later for a supplementary consultation over the telephone and to answer any questions. Epilepsy is unique among chronic, episodic disorders in that PWE lose their ability to make choices during a seizure and depend to a greater degree on the decisions of others including family, friends and colleagues. For this reason, we encourage the PWE to invite their support network to attend the patient education sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Clinic to Community Education Program
2022
N/A
~10

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
654 Previous Clinical Trials
413,176 Total Patients Enrolled
2 Trials studying Epilepsy
145 Patients Enrolled for Epilepsy
Ontario Brain InstituteOTHER
11 Previous Clinical Trials
3,020 Total Patients Enrolled
3 Trials studying Epilepsy
145 Patients Enrolled for Epilepsy
Kathy N Speechley, PhDPrincipal InvestigatorLondon Health Sciences Centre

Media Library

Clinic to Community Education Program Clinical Trial Eligibility Overview. Trial Name: NCT04248920 — N/A
Epilepsy Research Study Groups: Intervention Group, Waitlist Control Group
Epilepsy Clinical Trial 2023: Clinic to Community Education Program Highlights & Side Effects. Trial Name: NCT04248920 — N/A
Clinic to Community Education Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04248920 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to enroll in this medical study?

"Indeed, according to clinicaltrials.gov the medical experiment is actively recruiting patients. It was initially posted on June 15th 2022 and last modified three weeks prior, with a need for 96 participants at one site."

Answered by AI

How many participants has the clinical trial attracted thus far?

"Affirmative. Data on clinicaltrials.gov demonstrates that this research endeavour, which was originally revealed to the public on June 15th 2022, is still actively looking for participants. A total of 96 individuals are needed between a single medical centre."

Answered by AI
Recent research and studies
~4 spots leftby Mar 2025